Gaming and Leisure Properties Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Gaming and Leisure Properties Inc. Common Stock trades at $38.13 (market cap $11.15B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.16 (market cap $6.57B). The key difference: Gaming and Leisure Properties Inc. Common Stock is the larger of the two by market cap, and Gaming and Leisure Properties Inc. Common Stock pays a 8.56% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gaming and Leisure Properties Inc. Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 1 Days on average.
| GLPI | IOVA | |
|---|---|---|
Market Cap | $11.15B | $6.57B |
Volume | 1,865,490 | 11,838,721 |
Sector | Real Estate | Health |
52-Week High | $49.82 | $14.82 |
52-Week Low | $37.59 | $1.81 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $19.21B | $6.50B |
Dividend Yield | 8.56% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Iovance Biotherapeutics (IOVA) trades at $14.50, down 0.41% on the day, with a bullish technical signal from moving averages. The company shows strong revenue growth, with 2026 guidance raised to $410–420 million, but remains unprofitable with a net income margin of -89.09%. Recent news highlights institutional buying and positive analyst sentiment driven by accelerating adoption of its Amtagvi therapy.
The outlook is optimistic due to expanding TIL therapy applications and raised revenue guidance, but high cash burn and lack of profitability pose significant risks. Analyst consensus is strongly bullish with a $13.44 price target, though the stock faces volatility from clinical trial outcomes and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Gaming and Leisure Properties Inc. is a real estate investment trust that acquires, finances, and owns casino and gaming properties, which it leases to gaming operators under triple-net lease arrangements. It was the first publicly traded REIT focused on the gaming real estate sector in North America.
Read more on GLPI →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →